دورية أكاديمية
أعرض في EDS

Guidelines' recommendations for the treatment-resistant depression: A systematic review of their quality.

التفاصيل البيبلوغرافية
العنوان: Guidelines' recommendations for the treatment-resistant depression: A systematic review of their quality.
المؤلفون: Gabriel FC; Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, São Paulo, Brasil., Stein AT; Departamento de Saúde Coletiva, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brasil.; Gerência de Ensino e Pesquisa do Grupo Hospitalar Conceição, Porto Alegre, Rio Grande do Sul, Brasil., Melo DO; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, São Paulo, Brasil., Fontes-Mota GCH; Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, São Paulo, Brasil., Dos Santos IB; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, São Paulo, Brasil., Rodrigues CDS; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, São Paulo, Brasil., Dourado A; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, São Paulo, Brasil., Rodrigues MC; Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, São Paulo, Brasil., Fráguas R; Departamento e Instituto de Psiquiatria, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Divisão de Psiquiatria e Psicologia Hospital, São Paulo, Brasil., Florez ID; School of Rehabilitation Sciences, McMaster University, Hamilton, Ontario, Canada.; Department of Pediatrics, University of Antioquia, Medellín, Colombia.; Pediatric Intensive Care Unit, Clinica Las Americas-AUNA, Medellin, Colombia., Correia DT; Departamento de Psiquiatria e Psicologia da Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal., Ribeiro E; Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, São Paulo, Brasil.
المصدر: PloS one [PLoS One] 2023 Feb 06; Vol. 18 (2), pp. e0281501. Date of Electronic Publication: 2023 Feb 06 (Print Publication: 2023).
نوع المنشور: Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Depression*/therapy , Depression*/drug therapy , Electroconvulsive Therapy*, Humans ; Antidepressive Agents/therapeutic use ; Psychotherapy ; Lithium
مستخلص: Introduction: Depression is a serious and widespread mental health disorder. A significant proportion of patients with depression fail to remit after two antidepressant treatment trials, a condition named treatment-resistant depression (TRD). Clinical practice guidelines (CPGs) are instruments aimed to improve diagnosis and treatment. This study objective is to systematically appraise the quality and elaborate a comparison of high-quality CPGs with high-quality recommendations aimed at TRD.
Methods and Analysis: We searched several specialized databases and organizations that develop CPGs. Independent researchers assessed the quality of the CPGs and their recommendations using AGREE II and AGREE-REX instruments, respectively. We selected only high-quality CPGs that included definition and recommendations for TRD. We investigated their divergencies and convergencies as well as weak and strong points.
Results: Among seven high-quality CPGs with high-quality recommendations only two (Germany's Nationale Versorgungs Leitlinie-NVL and US Department of Veterans Affairs and Department of Defense-VA/DoD) included specific TRD definition and were selected. We found no convergent therapeutic strategy among these two CPGs. Electroconvulsive therapy is recommended by the NVL but not by the VA/DoD, while repetitive transcranial magnetic stimulation is recommended by the VA/DoD but not by the NVL. While the NVL recommends the use of lithium, and a non-routine use of thyroid or other hormones, psychostimulants, and dopaminergic agents the VA/DoD does not even include these drugs among augmentation strategies. Instead, the VA/DoD recommends ketamine or esketamine as augmentation strategies, while the NVL does not mention these drugs. Other differences between these CPGs include antidepressant combination, psychotherapy as a therapeutic augmentation, and evaluation of the need for hospitalization all of which are only recommended by the NVL.
Conclusions: High-quality CPGs for the treatment of depression diverge regarding the definition and use of the term TRD. There is also no convergent approach to TRD from currently high-quality CPGs.
Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: Ivan Florez is the current leader of the AGREE collaboration.
(Copyright: © 2023 Gabriel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
التعليقات: Update of: PLoS One. 2022 Apr 19;17(4):e0267323. (PMID: 35439270)
References: J Affect Disord. 2011 Jun;131(1-3):92-103. (PMID: 21144591)
Acta Psychiatr Scand. 2018 Jun;137(6):459-471. (PMID: 29577229)
CMAJ. 2010 Dec 14;182(18):E839-42. (PMID: 20603348)
PLoS One. 2020 Apr 21;15(4):e0231700. (PMID: 32315333)
Can J Psychiatry. 2017 Jan;62(1):11-23. (PMID: 27554483)
J Clin Psychiatry. 2007;68 Suppl 8:17-25. (PMID: 17640154)
Qual Saf Health Care. 2010 Dec;19(6):e58. (PMID: 21127089)
Psychopharmacology (Berl). 2014 Sep;231(18):3663-76. (PMID: 25038867)
Depress Anxiety. 1997;5(4):154-64. (PMID: 9338108)
Depress Anxiety. 2021 Apr;38(4):456-467. (PMID: 33528865)
CNS Drugs. 2009 Aug;23(8):627-47. (PMID: 19594193)
BMJ Open. 2022 Apr 1;12(4):e051918. (PMID: 35365512)
Med Clin (Barc). 2000;114 Suppl 2:14-8. (PMID: 10916800)
JAMA Netw Open. 2020 May 1;3(5):e205535. (PMID: 32459354)
BMC Psychiatry. 2019 Feb 20;19(1):76. (PMID: 30786870)
Arch Intern Med. 2012 Nov 26;172(21):1628-33. (PMID: 23089902)
Lancet. 2018 Apr 7;391(10128):1357-1366. (PMID: 29477251)
J Clin Psychiatry. 2006 May;67(5):688-95. (PMID: 16841617)
PLoS One. 2022 Apr 19;17(4):e0267323. (PMID: 35439270)
J Clin Epidemiol. 2020 Sep;125:191-197. (PMID: 32473992)
Neuropsychiatr Dis Treat. 2020 Jan 21;16:221-234. (PMID: 32021216)
Cien Saude Colet. 2020 May;25(5):1955-1966. (PMID: 32402025)
J Affect Disord. 2009 Jul;116(1-2):4-11. (PMID: 19007996)
JAMA Intern Med. 2019 Apr 1;179(4):553-560. (PMID: 30776060)
J Clin Psychiatry. 2009 Feb;70(2):177-84. (PMID: 19192471)
المشرفين على المادة: 0 (Antidepressive Agents)
9FN79X2M3F (Lithium)
تواريخ الأحداث: Date Created: 20230206 Date Completed: 20230208 Latest Revision: 20230407
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9901785
DOI: 10.1371/journal.pone.0281501
PMID: 36745622
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0281501